MSD Korea is bringing a subcutaneous formulation of its blockbuster cancer drug Keytruda to Korea, offering patients and ...
Korean researchers have developed inhalable nanoparticles that deliver an anticancer drug directly to the lungs, remaining there for up to 48 hours in mice while targeting both lung cancer cells and t ...
Shares of Ariio Holdings plunged about 18 percent in early trading Wednesday after the company scrapped its planned merger ...
Korea may need 12 to 20 proton therapy centers, each capable of treating about 1,000 patients a year, based on estimates of ...
NeoImmuneTech’s U.S. partner Tolerance Bio has added a clinical-stage IL-33 antibody to its thymus-focused pipeline alongside ...
Hanmi Pharmaceutical said on Tuesday that it will regain global rights to its cancer drug belvarafenib after Genentech ...
Lundbeck Korea said Wednesday that it has donated 15 million won ($10,500) to help low-income patients pay for medical ...
SK chemicals said Wednesday it received an AAA rating in MSCI's latest environmental, social and governance assessment, up ...
Only 113 pediatrics residents are currently training at hospitals across Korea, and nearly 80 percent are concentrated in ...
Celltrion said Tuesday it will participate in CPHI 2026 in Milan, Italy, from Oct. 6-8 to seek new CDMO and supply-chain ...
The National Cancer Center (NCC) and Beijing Cancer Hospital, also known as Peking University Cancer Hospital, are expanding ...
Pediatric obesity specialists in Korea called Monday for insurance-covered counseling, referral and follow-up care for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results